These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11510515)

  • 1. A new century approach for alcohol screen in the insurance industry.
    Bean P; Kleaver E; Roberts B; Harasymiw J
    J Insur Med; 2001; 33(2):183-8. PubMed ID: 11510515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early detection of alcohol consumption (EDAC) score in the identification of Heavy and at-risk drinkers from routine blood tests.
    Harasymiw JW; Vinson DC; Bean P
    J Addict Dis; 2000; 19(3):43-59. PubMed ID: 11076119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of alcohol misuse using a routine test panel: the early detection of alcohol consumption (EDAC) test.
    Harasymiw J; Seaberg J; Bean P
    Alcohol Alcohol; 2004; 39(4):329-35. PubMed ID: 15208166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using routine laboratory tests to detect heavy drinking in the general population.
    Harasymiw J; Seaberg J; Bean P
    J Addict Dis; 2006; 25(2):59-63. PubMed ID: 16785221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the EDAC test to monitor abstinence and relapses during outpatient treatment.
    Harasymiw J; Forster I; Bean P
    J Addict Dis; 2005; 24(3):101-13. PubMed ID: 16186087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Early Detection of Alcohol Consumption (EDAC) test shows better performance than gamma-glutamyltransferase (GGT) to detect heavy drinking in a large population of males and females.
    Harasymiw J; Bean P
    Med Sci Monit; 2007 Sep; 13(9):PI19-24. PubMed ID: 17767129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards.
    Arndt T; Keller T
    Forensic Sci Int; 2004 Nov; 146(1):9-16. PubMed ID: 15485716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alcohol Use Disorders Identification Test and carbohydrate-deficient transferrin in alcohol-related sickness absence.
    Hermansson U; Helander A; Brandt L; Huss A; Rönnberg S
    Alcohol Clin Exp Res; 2002 Jan; 26(1):28-35. PubMed ID: 11821651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences in C.D.T. testing.
    Roberts JW
    J Insur Med; 1996; 27(4):287-93. PubMed ID: 10163405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reproducibility of the early detection of alcohol consumption test using split samples analyzed in different laboratories.
    Bean P; Harasymiw J
    Alcohol Alcohol; 2011; 46(6):694-701. PubMed ID: 21784750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.
    Berner MM; Bentele M; Kriston L; Mänz C; Clement HW; Härter M; Mundle G
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1372-80. PubMed ID: 16899040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence.
    Bean P; Harasymiw J; Peterson CM; Javors M
    Alcohol Clin Exp Res; 2001 Feb; 25(2):309-16. PubMed ID: 11236848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined use of the early detection of alcohol consumption (EDAC) test and carbohydrate-deficient transferrin to identify heavy drinking behaviour in males.
    Harasymiw J; Bean P
    Alcohol Alcohol; 2001; 36(4):349-53. PubMed ID: 11468138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair analysis of fatty acid ethyl esters in the detection of excessive drinking in the context of fetal alcohol spectrum disorders.
    Kulaga V; Pragst F; Fulga N; Koren G
    Ther Drug Monit; 2009 Apr; 31(2):261-6. PubMed ID: 19258930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic validity of screening tests and laboratory markers in alcohol use disorders].
    Gül S; Akvardar Y; Taş G; Tuncel P
    Turk Psikiyatri Derg; 2005; 16(1):3-12. PubMed ID: 15793693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence.
    Helander A; Eriksson CJ;
    Alcohol Clin Exp Res; 2002 Jul; 26(7):1070-7. PubMed ID: 12170117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
    Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
    Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Mar; 26(3):332-9. PubMed ID: 11923585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
    Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
    Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.